about
mission / vision
our team
board members
executive leadership
scientists
careers
postdoctoral programs
internship programs
current job opportunities
| |
 |
Darrick Carter, PhD
Vice President, Adjuvant Technology
Darrick Carter is the Vice President of Adjuvant Technology
at IDRI. His work centers on new immunomodulatory agents
and formulations, as well as the process development
necessary to take vaccines and therapeutic candidates from
the lab to the clinic.
Darrick is a biochemist/biophysicist with over 10 years of
experience in the biotechnology industry developing
therapeutics and vaccines. He has founded five companies,
starting with a sole proprietorship biotech/internet startup,
Proteinchemist.com, in 2001. Darrick previously worked at
Corixa Corporation, where he led a new tuberculosis vaccine
into human clinical trials and assisted as group leader for
analytical biochemistry working on adjuvants and a
commercial, radiolabeled mAb for non-Hodgkins lymphoma.
In 2005, he founded and served as CEO of Protein
Advances Inc., a bioinformatics company with proprietary
drug discovery technologies using artificial neural nets.
Darrick also served as CSO at a specialty pharmaceutical
company focused on drug and device combinations, is a
founding member of a company focused on immunotherapy
in oncology, and a founding member of a device company
working on inflammatory disorders. Darrick sits on the
Scientific Advisory Boards of three local biotech companies
and hosts a web site for protein chemists. He has authored
over 30 peer-reviewed papers and is inventor/co-inventor on
more than 160 patent applications and issued patents.
Darrick received his BSc summa cum laude from the
department of Biochemistry and Biophysics at Oregon State
University. He received his PhD from the Department of
Biochemistry and Molecular Biology at Oregon Health
Sciences University.
|
|
